About Us

About SOLIS

Solis was founded with a clear vision:

To bridge the gap between unmet medical needs and underserved therapeutic areas in the pharmaceutical industry.

Solis is backed by private investors, is dedicated to establishing a strong presence in the specialty pharmaceutical space. Since launch, we have created a robust commercial front and distribution channels across the U.S.

our-expertise

Our Expertise

At Solis, we take pride in our deep-rooted expertise in sales and marketing. Our team of industry veterans brings decades of experience, ensuring that our products are strategically positioned in the market to achieve maximum reach and impact. We employ innovative marketing strategies and tap into our extensive network to ensure our medications are accessible to those who need them most.

strategic-partnerships

Strategic Partnerships

In the pharmaceutical industry, success is built on strong, reliable partnerships. At Solis, we collaborate with leading Contract Manufacturing Organizations (CMOs).

vision-icon

Our Vision

Solis’s vision is to create a company dedicated to marketing and distributing of branded and specialty products to address unmet medical needs and solve under served therapeutic area.

mission-icon

Our Mission

Solis's mission is to develop a rich portfolio of prescription medicines for the U.S. market in specific therapeutic areas, through partnerships, product acquisitions, and licensing. We aim to grow the company organically as well as inorganically by acquiring companies that focus on underserved therapeutic areas.

Our Values

Our Team

Solis Pharmaceuticals Inc. is a U.S. subsidiary of Primacure Ventures LLP. Primacure is headquartered in India and caters to multiple geographies like Europe, Africa, and LATAM. With decades of combined experience, the Solis team brings unparalleled expertise across every facet of the pharmaceutical industry.

From cutting-edge research and development to regulatory affairs, manufacturing, sales, and marketing, our experts are equipped to navigate the complexities of the healthcare landscape. This diverse skill set allows us to consistently deliver exceptional value and innovation in underserved therapeutic areas to our stakeholders.

Arun Nataraj
Advisor, Corporate Strategy & Portfolio Development

With 25+ years in the life sciences industry, Arun has led partnerships to develop and launch products across various dosage forms.

Lalit Mahapatra
Chief Financial Officer

As CFO, Lalit brings vast experience across multiple geographies.

Arlene Colligon
VP of Sales & Specialty Channels

An expert in building commercial operations since 2005. She has fostered relationships with major U.S. distributors, GPOs and Hospitals.

Mark Chick
Director of Institutional Sales

Mark Chick brings 10+ years of experience in go-to-market strategy and sales leadership, with a proven track record of building high-performing teams and driving multimillion-dollar growth across IDN, specialty, non-acute, retail, and GPO channels.

up-arrow